Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

Analysis of CD30/TNFRSF8 (Human) by MSD Hypersensitive Multi-Factor Electrochemiluminescence Analyzer (CAT#: STEM-MB-0087-LGZ)

Introduction

Leukocyte antigen cluster of differentiation 30 (CD30), also known as tumor necrosis factor receptor superfamily member 8 (TNFRSF8), is a membrane protein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. The CD30 protein is expressed by activated but not resting T cells and B cells. CD30 may play a role in the regulation of cell growth and transformation of activated lymphoblastic cells, and may also play an important role in human immunodeficiency virus replication. TRAF2 and TRAF5 can interact with this receptor and mediate signal transduction leading to NF-κB activation. As a positive regulator of apoptosis, the CD30 protein can induce cell death or proliferation depending on the cell type and has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body from autoimmunity. CD30 protein expression is upregulated in various hematological malignancies, and CD30 is also associated with leukocytes in patients with chronic inflammatory diseases such as lupus, asthma, and rheumatoid arthritis.




Principle

MSD electrochemiluminescence technology is mainly based on ultra-sensitive multi-factor electrochemiluminescence analyzer MES0 Sector600 or Quickplex SQ120. Through dot matrix technology, the detection of 10 indicators per well can be realized in the 96-hole graphite electrode plate. It can also be customized to realize the screening detection of 100 index wells in a 24-well plate.

Applications

Oncology & Cancer

Procedure

1. Coat the capture antibody on the well plate.
2. Add samples/calibrators.
3. Add detection antibody.
4. Read the plate and analyze the data.

Materials

• Sample Type: Serum, Plasma